Xaira Therapeutics Stock
HealthTechLooking to sell Xaira Therapeutics stock or options?
Xaira Therapeutics is dedicated to developing life-changing medicines by harnessing the transformative power of artificial intelligence. The company focuses on creating computational methods, models, data sets, platforms, and processes that enhance the ability of science to cure disease. Through these innovative approaches, Xaira Therapeutics empowers patients by developing novel therapeutics designed to address their medical needs.
Notable investors include:
Other investors include:
Sahsen Ventures, Rsquared, Longwood Fund, Foresite Capital, WRF Capital, Foresite Labs, F-Prime, Menlo Ventures, Deviation Capital, Parker Institute for Cancer Immunotherapy.